This article is 6 months old

Study suggests eating ultra-processed foods may accelerate early Parkinson's symptoms

Consumption of ultra-processed food is associated with an increased likelihood of having prodromal signs of Parkinson's disease - symptoms that precede the disease - says a study published in Neurology. The analysis is based on data from more than 42,000 healthcare professionals in the US, followed for up to 26 years.

07/05/2025 - 22:00 CEST
Expert reactions

250507 UPF Parkinson Maira EN

Maira Bes-Rastrollo

Co-coordinator of the working group on Nutrition of the Spanish Society of Epidemiology (SEE), Professor of Preventive Medicine and Public Health at the University of Navarra, and member of CIBERobn

Science Media Centre Spain

This new study, following a very sound scientific methodology, provides new evidence to suggest that what we eat today will have consequences for our mental health tomorrow. 

This is a follow-up study based on two large cohort studies at Harvard University, the cohort of American nurses and the cohort of health professionals with more than 42,000 participants [in total]. The researchers observed that those who consumed the most ultra-processed foods (on average 11 servings per day), foods characterised by being industrially processed and often containing a long list of ingredients with additives such as sweeteners, colourings, emulsifiers or flavour enhancers, were 2.5 times more likely to develop three or more non-motor prodromal signs of Parkinson's disease than those who on average consumed three ultra-processed foods per day. To a lesser extent, participants who consumed on average 6 ultra-processed foods were 1.5 times more likely to develop 3 or more prodromal signs including smell problems (hyposmia), constipation, probable REM sleep behaviour disorder, colour vision problems, daytime sleepiness, body pain and depressive symptoms. When each non-motor prodromal sign was analysed separately, a positive association was observed with REM sleep behaviour disorder, constipation, body pain and depressive symptoms. 

When looking at the different ultra-processed food groups, sweet snacks and sugary or sweetened beverages increased the risk of developing these prodromal signs the most. 

Looking at non-motor prodromal signs of Parkinson's is an advantage, as these appear ten to twenty years before clinical diagnosis, which provides an opportunity for early interventions to prevent the development of Parkinson's disease. However, it would be desirable to have further studies that also look at a relationship between ultra-processed food consumption and the incidence of Parkinson's disease diagnosis, not only with early non-motor signs of the disease. 

In any case, these results continue to support the need to discourage the consumption of ultra-processed foods, not only because of their increased risk with metabolic diseases, but also with mental illnesses, and the need to continue promoting the Mediterranean diet in the population, based on minimally processed foods with a high consumption of fruit, vegetables, legumes, whole grains, fish and olive oil.

The author has not responded to our request to declare conflicts of interest
EN

Eef - ultraprocesados párkinson EN

Eef Hogervorst

Professor of Psychology, Loughborough University

Science Media Centre UK

Firstly, the outcome term 'early symptoms of Parkinson’s disease' is a bit misleading as symptoms such as constipation, and body pain here found to be associated with consumption of Ultra Processed Foods (UPF) are quite common in ageing and are not necessarily indicative of Parkinson’s disease.
 
Even the most likely predictor of Parkinson’s disease – probably REM sleep disorder – is seen in 65% of Parkinson patients but also in 10% of controls, with low (65%) sensitivity for Parkinson's disease, even when people already have this disease (Kakazu, 2024). This symptom only shows relations with the highest intake of UPF.
 
Other symptoms like reduced sense of smell, daytime sleepiness, impaired colour vision and depression by themselves seem not related to consumption of UPF.
 
With regards to the UPF outcome, 30% of food consumption assessed by questionnaire was not agreed on and while experts apparently re-assessed these, it is not clear how they agreed on categorisation of foods, so whether they were UPF or not.
 
It seemed strange that non-UPF food included beef, pork, lamb chicken or turkey sandwich (all processed meats); cream; pancakes or waffles; pie, home-baked or readymade; popcorn; potato or
corn chips; soy milk; and tomato sauce, as well as distilled alcohol and dairy coffee.
 
Individual foods such as UPF breads or cereals and indeed microwaveable meals were by themselves not associated with the 'early Parkinson disease symptoms' while sauces, sweets, artificial sweetened drinks and desserts were as well as savoury snacks, animal and dairy products including yogurts.  Such foods are associated with diabetes mellitus and vascular (heart) disease, respectively, which can impact on brain disease because of their sugar and trans fat contents, respectively.
 
However, it is not the first study to show associations of UPF and brain disease.  We early wrote a piece on studies investigating dementia risk and processed meat consumption.  A healthy varied whole food diet is associated with prevention of many diseases including dementia.
 
Lastly, these two cohorts were mainly white health professionals so the results do not necessarily translate to everyone.
 
So this study may be affected by UPF categorisation as a predictor, where also not all UPF foods showed an association; the limited study group associations were assessed in (only mainly white health professionals and nurses) and also by the outcome, as these symptoms are not necessarily predictive of Parkinson’s disease, nor were these symptoms individually all associated with UPF consumption.

Conflict of interest:  “A previous consultancy for Proctor on omega 3 and folic acid supplement review to protect against dementia (these did not in meta-analyses), and unpaid but a travel reimbursed media appearance (breakfast TV BBC) to discuss the Lancet 2024 risk factors for dementia and her own articles including The Conversation piece on nutrition and dementia risk.  Eef also acted as unpaid but travel reimbursed consultant for NICE on menopausal HRT and dementia risk and has received travel reimbursement to speak at ESG and BMS conference on dementia prevention in 2024/2025.”

EN

Daniel J. van Wamelen - ultraprocesados párkinson EN

Daniel J. van Wamelen

Clinical Senior Lecturer in Neuroscience and Honorary Consultant Neurologist, Institute of Psychiatry, Psychology & Neuroscience, King’s College London (UK)

Science Media Centre UK

The findings in this study are interesting and appear to be based on solid research with conclusions well supported by the data.  However, it is important to highlight that the symptoms examined in this study are possible early signs of Parkinson’s disease, not definitive indicators that someone will go on to develop it.  The study did not track whether participants were diagnosed with Parkinson’s later on. 

Many of the individual symptoms noted, such as sleep disturbances, constipation, and mood changes, are common in the general population.  While the study found that people who ate more ultra-processed foods tended to report more of these non-motor symptoms, it did not find a direct increase in the risk of Parkinson’s disease itself.  That said, having more of these symptoms suggests a higher risk over time.  For example, a person experiencing a combination of REM sleep behaviour disorder, constipation, and depressive symptoms has a higher likelihood of developing Parkinson’s down the line, but the risk is not absolute.  To better understand the long-term implications, we would need a longer follow-up to see how many participants go on to develop Parkinson’s and how this is associated with their diet. 

In short, this is an interesting piece of research addressing important questions.  But the connection to Parkinson’s disease should be viewed with caution until more definitive evidence becomes available.

Conflict of interest: “Supported by research funding from CHDI Inc, MRC, and BRC; received travel grants and speaker fees for educational purposes from Bial Pharma; served on advisory boards for Britannia Pharmaceuticals and Invisio Pharma; received in kind contributions (equipment) from Chrono Eyewear BV for research projects.”

EN
Publications
Journal
Neurology
Authors

Peilu Wang et al.

Study types:
  • Research article
  • Peer reviewed
  • People
The 5Ws +1
Publish it
FAQ
Contact